Literature DB >> 16849901

Relationship between physician knowledge of hypertension and blood pressure control.

Barry L Carter1, Arthur Hartz, George Bergus, Jeffrey D Dawson, William R Doucette, Janyce J Stewart, Yinghui Xu.   

Abstract

The purpose of this study was to evaluate the cross-sectional relationship between physician knowledge of hypertension guidelines and blood pressure (BP) control. The authors evaluated a sample of primary care faculty (n=32) and a sample of their patients (n=613). When treating patients as independent observations, the authors found an inverse relationship (r=-0.524; p=0.002) where higher knowledge scores were associated with lower BP control. The authors conducted a multivariate analysis to accommodate the nonindependence due to random physician effects and found that there was no longer a significant association between knowledge and BP control, but there was still a trend (odds ratio=0.84; p=0.130). This study demonstrates that there is no evidence that high knowledge of hypertension guidelines will improve BP control rates and that higher knowledge may actually be associated with lower BP control. Strategies that are designed only to improve knowledge of hypertension guidelines are insufficient to improve BP control rates.

Entities:  

Mesh:

Year:  2006        PMID: 16849901      PMCID: PMC8109724          DOI: 10.1111/j.1524-6175.2006.05601.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  27 in total

1.  Chronic disease management: what will it take to improve care for chronic illness?

Authors:  E H Wagner
Journal:  Eff Clin Pract       Date:  1998 Aug-Sep

2.  Improving primary care for patients with chronic illness.

Authors:  Thomas Bodenheimer; Edward H Wagner; Kevin Grumbach
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

3.  Malpractice claims against family physicians are the best doctors sued more?

Authors:  J W Ely; J D Dawson; P R Young; B N Doebbeling; C J Goerdt; N C Elder; R S Olick
Journal:  J Fam Pract       Date:  1999-01       Impact factor: 0.493

4.  Antihypertensive Drug Utilization in Hypertensive Veterans With Complex Medication Profiles.

Authors:  Barry L. Carter; Daniel C. Malone; Sam L. Ellis; Robert C. Dombrowski
Journal:  J Clin Hypertens (Greenwich)       Date:  2000-05       Impact factor: 3.738

5.  Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure.

Authors:  M N Hill; D M Levine; P K Whelton
Journal:  Am J Public Health       Date:  1988-09       Impact factor: 9.308

6.  Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  D Siegel; J Lopez
Journal:  JAMA       Date:  1997-12-03       Impact factor: 56.272

7.  Improving adherence to guidelines for hypertension drug prescribing: cluster-randomized controlled trial of general versus patient-specific recommendations.

Authors:  Mary K Goldstein; Philip Lavori; Robert Coleman; Aneel Advani; Brian B Hoffman
Journal:  Am J Manag Care       Date:  2005-11       Impact factor: 2.229

8.  Nurse management for hypertension. A systems approach.

Authors:  Peter Rudd; Nancy Houston Miller; Judy Kaufman; Helena C Kraemer; Albert Bandura; George Greenwald; Robert F Debusk
Journal:  Am J Hypertens       Date:  2004-10       Impact factor: 2.689

9.  Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension.

Authors:  P E Bogden; R D Abbott; P Williamson; J K Onopa; L M Koontz
Journal:  J Gen Intern Med       Date:  1998-11       Impact factor: 5.128

10.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

View more
  7 in total

Review 1.  Antihypertensive prescribing: do we have reason to celebrate?

Authors:  Barry L Carter
Journal:  Hypertension       Date:  2006-09-18       Impact factor: 10.190

2.  Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention.

Authors:  Barry L Carter; William R Doucette; Carrie L Franciscus; Gail Ardery; Karen M Kluesner; Elizabeth A Chrischilles
Journal:  Pharmacotherapy       Date:  2010-03       Impact factor: 4.705

3.  Part II, provider perspectives: should patients be activated to request evidence-based medicine? A qualitative study of the VA project to implement diuretics (VAPID).

Authors:  Colin D Buzza; Monica B Williams; Mark W Vander Weg; Alan J Christensen; Peter J Kaboli; Heather Schacht Reisinger
Journal:  Implement Sci       Date:  2010-03-18       Impact factor: 7.327

4.  Using an established telehealth model to train urban primary care providers on hypertension management.

Authors:  Christopher Masi; Tamara Hamlish; Andrew Davis; Kristine Bordenave; Stephen Brown; Brenda Perea; Glen Aduana; Marcus Wolfe; George Bakris; Daniel Johnson
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-12-02       Impact factor: 3.738

5.  Comparison of two methods of teaching hypertension in under graduate medical students: "planned lecture" versus "cooperative learning".

Authors:  Zahra Sobhani; Farokhlagha Ahmadi; Mohammad Jalili; Zinat Nadia Hatmi; Orkideh Olang; Khadijeh Eslami; Seyed Mansoor Gatmiri
Journal:  Nephrourol Mon       Date:  2012-03-01

6.  A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control.

Authors:  Barry L Carter; George R Bergus; Jeffrey D Dawson; Karen B Farris; William R Doucette; Elizabeth A Chrischilles; Arthur J Hartz
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-04       Impact factor: 3.738

7.  Patient and provider perceptions of hypertension treatment: do they agree?

Authors:  Peter J Kaboli; Daniel M Shivapour; Michael S Henderson; Mitchell J Barnett; Areef Ishani; Barry L Carter
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-06       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.